Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic markers of inflammation in stable bronchiectasis

C B Wilson1, P W Jones, C J O'Leary

  • 1Host Defence Unit, Imperial College of Science Technology and Medicine, National Heart and Lung Institute, London, UK.

The European Respiratory Journal
|November 17, 1998
PubMed
Summary

Patients with bronchiectasis show elevated systemic inflammation markers even when stable. These inflammation markers, like neutrophil count, correlate with disease severity and impact lung function and quality of life.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunologic aspects of renal diseases.

JAMA·1992
Same author

Magnetic resonance imaging of tuberculum sellae meningiomas: preventing preoperative misdiagnosis as pituitary macroadenoma.

Neurosurgery·1992
Same author

Ontogeny of T lymphocyte function in the neonate.

American journal of reproductive immunology (New York, N.Y. : 1989)·1992
Same author

Heparin decreases mesangial matrix accumulation after selective antibody-induced mesangial cell injury.

Journal of the American Society of Nephrology : JASN·1992
Same author

Positron emission tomography for tumour assessment.

NMR in biomedicine·1992
Same author

Radiosurgery: a new application?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1992

Area of Science:

  • Pulmonary Medicine
  • Immunology

Background:

  • Bronchiectasis is characterized by local and systemic inflammation during exacerbations.
  • Persistent inflammation in stable bronchiectasis may impact overall health and disease progression.

Purpose of the Study:

  • To investigate systemic inflammation markers in stable non-cystic fibrosis bronchiectasis patients.
  • To assess the relationship between inflammation markers, disease extent, lung function, sputum bacteriology, and health-related quality of life (HRQoL).

Main Methods:

  • Studied 87 non-cystic fibrosis bronchiectasis patients during a stable phase.
  • Measured systemic inflammation markers, computed tomographic scan extent, lung function, sputum bacteriology, and HRQoL.

Main Results:

Related Experiment Videos

  • Elevated systemic inflammation markers were observed in stable patients.
  • White cell count, neutrophil count, and erythrocyte sedimentation rate correlated with disease extent and reduced lung function.
  • C-reactive protein and white cell count correlated with specific HRQoL components.
  • Sputum bacteriology did not correlate with inflammation markers.

    • Conclusions:

    • Stable bronchiectasis patients exhibit elevated systemic inflammation.
    • Inflammation markers, particularly neutrophil count, are linked to disease severity.
    • Inflammation levels may influence disease progression and patient health status.